Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Orbital recurrence of iris melanoma 21 years after enucleation.

Literature DB >> 28882848

Orbital recurrence of iris melanoma 21 years after enucleation.

Emilie Bergeron¹, Nadia Lihimdi¹, Dan Bergeron^1,2, Solange Landreville^2,3.

Abstract

We present the case of a 56-year-old man who developed a neoplasm of epithelioid histology in his anophthalmic left orbit 21 years after he underwent enucleation for a spindle cell iris melanoma. The recurrent tumour was managed by orbital exenteration. Neither further recurrence nor metastasis was diagnosed over a 5-year follow-up period. This case, along with five other similar cases in the literature,1-3 emphasises the importance of long-term follow-up after treatment of iris melanoma. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities: Disease Species

Keywords: oncology; ophthalmology; pathology; surgical oncology

Mesh：

Year: 2017 PMID： 28882848 PMCID： PMC5604697 DOI： 10.1136/bcr-2017-221137

Source DB: PubMed Journal: BMJ Case Rep ISSN： 1757-790X

20 in total

1. Surgical treatment of iris and ciliary body melanoma: follow-up of a 25-year series of patients.

Authors: Stefan Klauber; Peter K Jensen; Jan U Prause; Svend V Kessing
Journal: Acta Ophthalmol Date: 2010-04-28 Impact factor: 3.761

2. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases.

Authors: Carol L Shields; Swathi Kaliki; Minoru Furuta; Arman Mashayekhi; Jerry A Shields
Journal: Retina Date: 2012-07 Impact factor: 4.256

3. Clinical use of ultrasound biomicroscopy.

Authors: C J Pavlin; K Harasiewicz; M D Sherar; F S Foster
Journal: Ophthalmology Date: 1991-03 Impact factor: 12.079

4. Iris melanoma: risk factors for metastasis in 169 consecutive patients.

Authors: C L Shields; J A Shields; M Materin; E Gershenbaum; A D Singh; A Smith
Journal: Ophthalmology Date: 2001-01 Impact factor: 12.079

5. Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study.

Authors: Samira Khan; Paul T Finger; Guo-Pei Yu; Lubna Razzaq; Martine J Jager; Rob J W de Keizer; Per Sandkull; Stefan Seregard; Daniel Gologorsky; Amy C Schefler; Timothy G Murray; Tero Kivelä; Gian Paolo Giuliari; Hugh McGowan; E Rand Simpson; Christine Corriveau; Sarah E Coupland; Bertil E Damato
Journal: Arch Ophthalmol Date: 2011-09-12

6. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.

Authors: Carol L Shields; Minoru Furuta; Archana Thangappan; Saya Nagori; Arman Mashayekhi; David R Lally; Cecilia C Kelly; Danielle S Rudich; Anand V Nagori; Oojwala A Wakade; Sonul Mehta; Lauren Forte; Andrew Long; Elaina F Dellacava; Bonnie Kaplan; Jerry A Shields
Journal: Arch Ophthalmol Date: 2009-08

Orbital recurrence of iris melanoma 21 years after enucleation.

1. Surgical treatment of iris and ciliary body melanoma: follow-up of a 25-year series of patients.

2. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases.

3. Clinical use of ultrasound biomicroscopy.

4. Iris melanoma: risk factors for metastasis in 169 consecutive patients.

5. Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study.

6. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.

7. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.

8. Clinical and ultrasound biomicroscopy features associated with growth in iris melanocytic lesions.

9. The T1799A BRAF mutation is present in iris melanoma.

10. Uveal melanoma.

1. Delayed recurrence of an iridociliary malignant melanoma 180° from the primary tumor.